HomeCompareGBLX vs JEPQ

GBLX vs JEPQ: Dividend Comparison 2026

GBLX yields 666666.67% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBLX wins by $3843184858461165056.00M in total portfolio value
10 years
GBLX
GBLX
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3843184858461165056.00M
Annual income
$2,951,404,776,098,759,000,000,000.00
Full GBLX calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — GBLX vs JEPQ

📍 GBLX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGBLXJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GBLX + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GBLX pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GBLX
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$2,508,694,059,683,945,000,000,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, GBLX beats the other by $2,508,694,059,683,945,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GBLX + JEPQ for your $10,000?

GBLX: 50%JEPQ: 50%
100% JEPQ50/50100% GBLX
Portfolio after 10yr
$1921592429230582528.00M
Annual income
$1,475,702,388,049,379,400,000,000.00/yr
Blended yield
76.80%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GBLX buys
0
JEPQ buys
0
No recent congressional trades found for GBLX or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGBLXJEPQ
Forward yield666666.67%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$3843184858461165056.00M$44.8K
Annual income after 10y$2,951,404,776,098,759,000,000,000.00$2,152.59
Total dividends collected$3777696863071325696.00M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: GBLX vs JEPQ ($10,000, DRIP)

YearGBLX PortfolioGBLX Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$33,344,033$33,333,333.33$11,930$1,110.39+$33.33MGBLX
2$51,973,424,741$51,937,746,625.13$14,133$1,224.34+$51973.41MGBLX
3$37,885,279,905,810$37,829,668,341,337.28$16,632$1,340.46+$37885279.89MGBLX
4$12,926,234,563,052,674$12,885,697,313,553,460.00$19,454$1,457.97+$12926234563.03MGBLX
5$2,068,281,583,056,657,700$2,054,450,512,074,191,400.00$22,626$1,576.08+$2068281583056.64MGBLX
6$155,823,080,460,537,230,000$153,610,019,166,666,620,000.00$26,175$1,694.09+$155823080460537.19MGBLX
7$5,574,621,214,635,156,000,000$5,407,890,518,542,381,000,000.00$30,133$1,811.32+$5574621214635156.00MGBLX
8$96,370,936,431,909,830,000,000$90,406,091,732,250,210,000,000.00$34,531$1,927.17+$96370936431909824.00MGBLX
9$833,439,329,310,660,000,000,000$730,322,427,328,516,400,000,000.00$39,403$2,041.08+$833439329310659968.00MGBLX
10$3,843,184,858,461,165,000,000,000$2,951,404,776,098,759,000,000,000.00$44,787$2,152.59+$3843184858461165056.00MGBLX

GBLX vs JEPQ: Complete Analysis 2026

GBLXStock

GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.

Full GBLX Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this GBLX vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GBLX vs SCHDGBLX vs JEPIGBLX vs OGBLX vs KOGBLX vs MAINGBLX vs XYLDGBLX vs QYLDGBLX vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.